Bartonellosis Therapeutics Market Insights, Research and Growth Factor till 2033
According to a recent report published by Future Market Insights, the global bartonellosis therapeutics market is slated to grow at a CAGR of 12% from 2023 to 2033, reaching a market value of US$ 3.72 Billion by the end of the said period of assessment. A robust product pipeline, in addition to upcoming launches, propelling the market growth. Growing R&D investments by major manufacturers for orphan-developing drugs and advanced product offerings are key market determinants. There were 791 prospective orphan drug applicants in clinical trials for the treatment of rare conditions in 2021. The market for bartonellosis therapeutics is expected to grow over the forecast period because, without treatment, the mortality rate increase rapidly. Bartonellosis joins a dormant stage, accompanied by recurrence and the advancement of a chronic phase, the Peruvian wart, with the pathogen still present in the body. Antibiotic demand is rapidly increasing as a result of an increase in cat scratch